- Home
- RAPT vs CCEL Comparison
RAPT vs CCEL Comparison
Compare RAPT & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- CCEL
- Stock Information
- Founded
- RAPT 2015
- CCEL 1989
- Country
- RAPT United States
- CCEL United States
- Employees
- RAPT N/A
- CCEL N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- CCEL Managed Health Care
- Sector
- RAPT Health Care
- CCEL Health Care
- Exchange
- RAPT Nasdaq
- CCEL Nasdaq
- Market Cap
- RAPT 59.1M
- CCEL 50.0M
- IPO Year
- RAPT 2019
- CCEL 1997
- Fundamental
- Price
- RAPT $1.25
- CCEL $7.71
- Analyst Decision
- RAPT Hold
- CCEL
- Analyst Count
- RAPT 10
- CCEL 0
- Target Price
- RAPT $6.00
- CCEL N/A
- AVG Volume (30 Days)
- RAPT 627.1K
- CCEL 15.6K
- Earning Date
- RAPT 03-06-2025
- CCEL 04-14-2025
- Dividend Yield
- RAPT N/A
- CCEL 3.24%
- EPS Growth
- RAPT N/A
- CCEL N/A
- EPS
- RAPT N/A
- CCEL N/A
- Revenue
- RAPT N/A
- CCEL $31,838,476.00
- Revenue This Year
- RAPT N/A
- CCEL $3.97
- Revenue Next Year
- RAPT N/A
- CCEL $0.91
- P/E Ratio
- RAPT N/A
- CCEL N/A
- Revenue Growth
- RAPT N/A
- CCEL 1.95
- 52 Week Low
- RAPT $0.79
- CCEL $4.47
- 52 Week High
- RAPT $10.05
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- RAPT 53.72
- CCEL 48.98
- Support Level
- RAPT $1.10
- CCEL $7.26
- Resistance Level
- RAPT $1.30
- CCEL $8.20
- Average True Range (ATR)
- RAPT 0.09
- CCEL 0.54
- MACD
- RAPT 0.02
- CCEL -0.02
- Stochastic Oscillator
- RAPT 72.00
- CCEL 34.15
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.